Alopecia associated with the use of semaglutide and tirzepatide: A disproportionality analysis using the FDA adverse event reporting system ( FAERS ) from 2022 to 2023
Journal of the European Academy of Dermatology and Venereology · 2025-02 · 39 (2)
DOI: 10.1111/jdv.20197 ↗Kurz gefasst
Leserbrief in der Zeitschrift Journal of the European Academy of Dermatology and Venereology, online erschienen am 24.06.2024. Verfasst von Hannah Godfrey und 3 weiteren Autor:innen. Beteiligte Einrichtung: University of Arizona College of Medicine-Tucson, Tucson, Arizona, USA. Die Arbeit wurde bisher 55-mal zitiert (Crossref) und nennt 9 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Autor:innen und Institutionen
- University of Arizona College of Medicine-Tucson, Tucson, Arizona, USA.
- Division of Dermatology, University of Arizona College of Medicine-Tucson, Tucson, Arizona, USA.
ORCID-Profile: Hannah Godfrey, Zachary Leibovit-Reiben
Zitieren
APA
Godfrey, H., Leibovit-Reiben, Z., Jedlowski, P., & Thiede, R. (2025). Alopecia associated with the use of semaglutide and tirzepatide: A disproportionality analysis using the FDA adverse event reporting system ( FAERS ) from 2022 to 2023. Journal of the European Academy of Dermatology and Venereology, 39(2). https://doi.org/10.1111/jdv.20197
Vancouver
Godfrey H, Leibovit-Reiben Z, Jedlowski P, Thiede R. Alopecia associated with the use of semaglutide and tirzepatide: A disproportionality analysis using the FDA adverse event reporting system ( FAERS ) from 2022 to 2023. Journal of the European Academy of Dermatology and Venereology. 2025;39(2). doi:10.1111/jdv.20197
BibTeX
@article{Godfrey2025,
author = {Godfrey, Hannah and Leibovit-Reiben, Zachary and Jedlowski, Patrick and Thiede, Rebecca},
title = {Alopecia associated with the use of semaglutide and tirzepatide: A disproportionality analysis using the FDA adverse event reporting system ( FAERS ) from 2022 to 2023},
journal = {Journal of the European Academy of Dermatology and Venereology},
year = {2025},
volume = {39},
number = {2},
doi = {10.1111/jdv.20197}
}
EUVIMED